Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure.
about
Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and In silico Assessment of Metabolic Drug-Drug Interactions Involving Modafinil.Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.Development and validation of a micellar liquid chromatographic method to determine three antitumorals in plasma.
P2860
Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Kinase inhibitor pharmacokinet ...... idual variability in exposure.
@en
type
label
Kinase inhibitor pharmacokinet ...... idual variability in exposure.
@en
prefLabel
Kinase inhibitor pharmacokinet ...... idual variability in exposure.
@en
P2093
P2860
P50
P1476
Kinase inhibitor pharmacokinet ...... vidual variability in exposure
@en
P2093
Andrew Rowland
Angela Rowland
John O Miners
Madelé van Dyk
P2860
P356
10.1080/17425255.2016.1229303
P407
P50
P577
2016-09-01T00:00:00Z